Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Operating Income Loss of -$183.9 thousand for the year ending 2024.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed a decrease of -180.7% in Operating Income Loss from 2023 to 2024.
- This data is from Cordyceps Sunshine Biotech Holdings Co., Ltd.'s annual report (Form 10-K), filed with the SEC on June 13, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2021 to 2024), Cordyceps Sunshine Biotech Holdings Co., Ltd.'s Operating Income Loss has declined by 54.0%.
- Historical annual values: Fiscal year 2024: -$183.9 thousand | Fiscal year 2023: $227.8 thousand | Fiscal year 2022: -$415.1 thousand | Fiscal year 2021: -$119.4 thousand.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: